Novel biomarkers of diabetic kidney disease: current status and potential clinical application Federica BaruttaStefania BelliniGabriella Gruden Review Article 02 February 2021 Pages: 819 - 830
The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19 Harsh ShahMd Shahjalal Hossain KhanVijay Hegde Review Article 15 February 2021 Pages: 831 - 843
The long-term metabolic and neurocognitive risks in offspring of women with type 1 diabetes mellitus Gilles VanhandsaemeKatrien Benhalima Review Article 15 March 2021 Pages: 845 - 858
Vascular complications of diabetes: natural history and corresponding risks of dementia in a national cohort of adults with diabetes Po-Yin ChangI.-T.ing WangHao-Min Cheng Original Article 23 February 2021 Pages: 859 - 867
Sodium–glucose cotransporter 2 inhibitors as an add-on therapy to insulin for type 1 diabetes mellitus: Meta-analysis of randomized controlled trials Lunwen RaoChenhong RenXuefeng Li Original Article Open access 02 March 2021 Pages: 869 - 880
Liraglutide targets the gut microbiota and the intestinal immune system to regulate insulin secretion Julie CharpentierFrancois BriandEstelle Grasset Original Article 15 March 2021 Pages: 881 - 897
Telehealth strategy to mitigate the negative psychological impact of the COVID-19 pandemic on type 2 diabetes: A randomized controlled trial Janine AlessiGiovana Berger de OliveiraGabriela Heiden Telo Original Article 15 March 2021 Pages: 899 - 909
The impact of parental risk factors on the risk of stroke in type 1 diabetes Anni YlinenStefanie Hägg-Holmbergon behalf of the FinnDiane Study Group Original Article Open access 15 March 2021 Pages: 911 - 917
Telemedicine and urban diabetes during COVID-19 pandemic in Milano, Italy during lock-down: epidemiological and sociodemographic picture Livio LuziMichele CarrubaAndrea Lenzi Original Article Open access 19 March 2021 Pages: 919 - 927
Carotid intima-media thickness and arterial stiffness in relation to cerebral small vessel disease in neurologically asymptomatic individuals with type 1 diabetes Jussi InkeriAnniina TynjäläFinnDiane Study Group Original Article Open access 20 March 2021 Pages: 929 - 937
The interaction between metabolic syndrome and physical activity, and risk for gestational diabetes mellitus Ashleigh K. SchneiderShalem Y. LeemaqzJessica A. Grieger Original Article 20 March 2021 Pages: 939 - 947
Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting Roberto ScicaliAntonino Di PinoSalvatore Piro Original Article Open access 21 March 2021 Pages: 949 - 957
Impact of lockdown during COVID-19 emergency on glucose metrics of children and adolescents with type 1 diabetes in Piedmont, Italy Davide TintiSilvia SavastioIvana Rabbone Short Communication 15 March 2021 Pages: 959 - 961
Ramadan fasting and type 1 diabetes: on a case successfully managed with an integrated system based on predictive low-glucose suspend algorithm Marina ValenzanoElena GamarraGiorgio Grassi Case Report Open access 08 March 2021 Pages: 963 - 966
Advanced hybrid closed-loop system: first successful clinical case after total pancreatectomy A. RizziL. TartaglioneD. Pitocco Case Report Open access 16 April 2021 Pages: 967 - 969
Answer to: Diabetes distress and peripheral neuropathy are associated with medication non-adherence in individuals with type 2 diabetes in primary care Isabella Rodrigues LimaAmanda SantinChaiana Esmeraldino Mendes Marcon Letter to the Editor 21 May 2021 Pages: 971 - 972
“Answer to: Diabetes distress and peripheral neuropathy are associated with medication non-adherence in individuals with type 2 diabetes in primary care”—authors’ reply Zhi Peng ZhangM. PremikhaKavita Venkataraman Letter to the Editor 24 May 2021 Pages: 973 - 973
